Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant options: venlafaxine in perspective

M E Thase1

  • 1Western Psychiatric Institute and Clinic, University of Pittsburgh, Pennsylvania, USA.

Journal of Clinical Psychopharmacology
|June 1, 1996
PubMed
Summary

This study reviews antidepressant options, focusing on venlafaxine. It highlights the importance of safety and tolerability in managing depression, a condition linked to brain chemical imbalances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression.

Brain stimulation·2021
Same author

Targeting location relates to treatment response in active but not sham rTMS stimulation.

Brain stimulation·2021
Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015
Same author

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Acta psychiatrica Scandinavica·2013
Same author

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.

Journal of affective disorders·2013
Same author

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).

The pharmacogenomics journal·2013

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Depression is frequently associated with imbalances in brain neurotransmitter systems, specifically norepinephrine and serotonin.
  • Antidepressant medications are designed to target these neurochemical alterations.
  • Individual antidepressant efficacy and side effect profiles are influenced by their mechanisms, including receptor blockade and neurotransmitter reuptake inhibition.

Purpose of the Study:

  • To provide an overview of available antidepressant treatment options.
  • To emphasize the critical role of safety and tolerability in long-term depression management.
  • To specifically examine the antidepressant venlafaxine.

Main Methods:

  • Review of existing literature on antidepressant pharmacology and clinical use.
  • Analysis of mechanisms of action for various antidepressant classes.
  • Focus on safety, tolerability, and treatment phases for depression.

Main Results:

  • Antidepressant agents differ in their effects on receptor blockade and neurotransmitter reuptake, impacting safety and tolerability.
  • Complete recovery is the goal of antidepressant therapy, involving distinct treatment phases.
  • Safety and tolerability are paramount due to depression's recurrent and chronic nature.

Conclusions:

  • Understanding the neurochemical basis of depression is key to developing effective treatments.
  • Venlafaxine represents a significant option within the spectrum of antidepressant therapies.
  • Optimizing antidepressant selection requires careful consideration of individual patient needs and treatment goals.

Related Experiment Videos